This sets the basis for our future work aimed at a comprehensive study of the dynamic range and kinetics of interaction as a function of the external biochemical factors acting on p53•MDM2 complex, even at the nM range, with the final aim of the low-cost investigation of molecules with pharmacological activity against cancer. This evidence concerns the gene TP53 and cancer.